⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TGTX News
TG Therapeutics, Inc.
TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
globenewswire.com
TGTX
TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance
globenewswire.com
TGTX
TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update
globenewswire.com
TGTX
TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI
globenewswire.com
TGTX